Published by Josh White on 28th March 2022
(Sharecast News) - Brain health technology developer Cambridge Cognition has won a contract worth just over £1m with an unnamed "top 10" pharmaceutical company, it announced on Monday, to provide digital cognitive assessments for a pivotal phase 3 autoimmune disease trial.
URL: http://www.digitallook.com/dl/news/story/32562674/...